Literature DB >> 21366357

Structural chemistry of the histone methyltransferases cofactor binding site.

Valérie Campagna-Slater1, Man Wai Mok, Kong T Nguyen, Miklos Feher, Rafael Najmanovich, Matthieu Schapira.   

Abstract

Histone methyltransferases (HMTs) transfer a methyl group from the cofactor S-adenosyl methionine to lysine or arginine residues on histone tails, thereby regulating chromatin compaction, binding of effector proteins and gene transcription. HMTs constitute an emerging target class in diverse disease areas, and selective chemical probes are necessary for target validation. Potent and selective competitors of the substrate peptide have been reported, but the chemical tractability of the cofactor binding site is poorly understood. Here, a systematic analysis of this site across structures of 14 human HMTs or close homologues was conducted. The druggability, interaction hotspots, and diversity of the cofactor binding pocket were dissected. This analysis strongly suggests that this site is chemically tractable. General principles underlying tight binding and specific guidelines to achieve selective inhibition are presented.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21366357     DOI: 10.1021/ci100479z

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  32 in total

Review 1.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

2.  Discovery of Potent Small-Molecule Inhibitors of MLL Methyltransferase.

Authors:  Ting-Rong Chern; Liu Liu; Elyse Petrunak; Jeanne A Stuckey; Mi Wang; Denzil Bernard; Haibin Zhou; Shirley Lee; Yali Dou; Shaomeng Wang
Journal:  ACS Med Chem Lett       Date:  2020-05-14       Impact factor: 4.345

3.  Structure of human SMYD2 protein reveals the basis of p53 tumor suppressor methylation.

Authors:  Li Wang; Ling Li; Hailong Zhang; Xiao Luo; Jingquan Dai; Shaolian Zhou; Justin Gu; Jidong Zhu; Peter Atadja; Chris Lu; En Li; Kehao Zhao
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

4.  Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.

Authors:  Wenyu Yu; David Smil; Fengling Li; Wolfram Tempel; Oleg Fedorov; Kong T Nguyen; Yuri Bolshan; Rima Al-Awar; Stefan Knapp; Cheryl H Arrowsmith; Masoud Vedadi; Peter J Brown; Matthieu Schapira
Journal:  Bioorg Med Chem       Date:  2013-01-30       Impact factor: 3.641

5.  Quantitative proteomic discovery of dynamic epigenome changes that control human cytomegalovirus (HCMV) infection.

Authors:  Christine M O'Connor; Peter A DiMaggio; Thomas Shenk; Benjamin A Garcia
Journal:  Mol Cell Proteomics       Date:  2014-07-01       Impact factor: 5.911

Review 6.  Protein arginine methylation: from enigmatic functions to therapeutic targeting.

Authors:  Qin Wu; Matthieu Schapira; Cheryl H Arrowsmith; Dalia Barsyte-Lovejoy
Journal:  Nat Rev Drug Discov       Date:  2021-03-19       Impact factor: 84.694

7.  Structure-guided design of fluorescent S-adenosylmethionine analogs for a high-throughput screen to target SAM-I riboswitch RNAs.

Authors:  Scott F Hickey; Ming C Hammond
Journal:  Chem Biol       Date:  2014-02-20

Review 8.  H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor development.

Authors:  David S Rogawski; Jolanta Grembecka; Tomasz Cierpicki
Journal:  Future Med Chem       Date:  2016-08-22       Impact factor: 3.808

9.  Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors.

Authors:  Wenyu Yu; Emma J Chory; Amy K Wernimont; Wolfram Tempel; Alex Scopton; Alexander Federation; Jason J Marineau; Jun Qi; Dalia Barsyte-Lovejoy; Joanna Yi; Richard Marcellus; Roxana E Iacob; John R Engen; Carly Griffin; Ahmed Aman; Erno Wienholds; Fengling Li; Javier Pineda; Guillermina Estiu; Tatiana Shatseva; Taraneh Hajian; Rima Al-Awar; John E Dick; Masoud Vedadi; Peter J Brown; Cheryl H Arrowsmith; James E Bradner; Matthieu Schapira
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

10.  Sinefungin derivatives as inhibitors and structure probes of protein lysine methyltransferase SETD2.

Authors:  Weihong Zheng; Glorymar Ibáñez; Hong Wu; Gil Blum; Hong Zeng; Aiping Dong; Fengling Li; Taraneh Hajian; Abdellah Allali-Hassani; Maria F Amaya; Alena Siarheyeva; Wenyu Yu; Peter J Brown; Matthieu Schapira; Masoud Vedadi; Jinrong Min; Minkui Luo
Journal:  J Am Chem Soc       Date:  2012-10-23       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.